GlycoMimetics, Inc. (NASDAQ: GLYC) announced today that data from two drug candidates in its clinical pipeline, GMI-1271 and rivipansel (formerly known as GMI-1070), will be featured during four oral presentations and two poster sessions at the 56th American Society of Hematology (ASH) Annual Meeting and Exposition. ASH is being held December 6-9, 2014, at the Moscone Center in San Francisco.
Help employers find you! Check out all the jobs and post your resume.
Help employers find you! Check out all the jobs and post your resume.
